FindTrial
Sign In

Timolol Maleate

DRUG10 trials

Sponsors

Beacon Therapeutics (USA) Inc., National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Pharmaceutical Research Network, Vistakon Pharmaceuticals, Santen Oy

Conditions

Anterior Ischemic Optic NeuropathyChronic WoundsEsophageal and Gastric VaricesExfoliation SyndromeGlaucoma, Open-AngleGlaucoma, PigmentaryGlaucoma; DrugsHealthy

Phase 1

Interaction Study of Timolol Eye Drops and Paroxetine Capsules
CompletedNCT00879099
Santen OyHealthy
Start: 2009-04-30End: 2010-01-31Target: 12Updated: 2010-01-28
Treatment Study for Ischemic Optic Neuropathy With Opthalmic Timolol Maleate 0.5%
WithdrawnNCT01607671
Fraser HealthAnterior Ischemic Optic Neuropathy, Ischemic Optic Neuropathy, Optic Neuropathy, Anterior Ischemic +1
Start: 2012-06-30End: 2013-11-30Updated: 2015-05-25

Phase 2

BOL-303259-X With Timolol 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension
CompletedNCT01707381
Bausch & Lomb IncorporatedOcular Hypertension, Open Angle Glaucoma
Start: 2012-11-30End: 2014-02-28Updated: 2018-09-04
Study to Evaluate QLS-101 Compared to Timolol Maleate Eye Drops in Subjects With High Eye Pressure (Glaucoma or Ocular Hypertension).
CompletedNCT04830397
Qlaris Bio, Inc.Ocular Hypertension, Primary Open Angle Glaucoma
Start: 2021-03-31End: 2022-02-17Updated: 2025-01-17

Phase 3

Prevention of Esophageal Varices by Beta-Adrenergic Blockers
CompletedNCT00006398
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Esophageal and Gastric Varices, Liver Cirrhosis, Portal Hypertension
Start: 1993-08-31End: 2002-09-30Updated: 2017-06-01
A Randomized, Controlled, Masked, Multi-center Study Evaluating the Efficacy, Safety, and Tolerability of Two Doses of AGTC-501 Compared to an Untreated Control Group in Male Participants with X-linked Retinitis Pigmentosa
WithdrawnCTIS2024-511181-36-00
Beacon Therapeutics (USA) Inc.X-linked retinitis pigmentosa (XLRP)
Target: 5Updated: 2024-09-17

Phase 4

Assessing Cosopt Switch Patients
CompletedNCT00273442
Pharmaceutical Research NetworkExfoliation Syndrome, Glaucoma, Pigmentary, Ocular Hypertension +1
Start: 2005-11-30End: 2007-04-30Target: 60Updated: 2008-11-19
Peripapillary Blood Flow After Use of Anti-glaucoma Medications: An OCT Angiography Study
CompletedNCT03323164
Wills EyeGlaucoma; Drugs, Normal Tension Glaucoma, Primary Open-angle Glaucoma
Start: 2017-07-10End: 2020-05-30Updated: 2020-12-31

Unknown Phase

A Comfort Survey of Open-angle Glaucoma or Ocular Hypertension Patients Treated With 2 Drugs
CompletedNCT00823043
Vistakon PharmaceuticalsOcular Hypertension, Open-angle Glaucoma
Start: 2009-01-31End: 2009-07-31Updated: 2015-03-06
Absorption and Safety of Topical Timolol to Treat Chronic Wounds
CompletedNCT04903366
VA Northern California Health Care SystemChronic Wounds, Glaucoma, Open-Angle
Start: 2017-11-21End: 2020-01-14Updated: 2021-05-27